Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | GRM8 | O00222 | 1/20 | 0.50 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | KMO | O15229 | 1/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6159827 | 1.00 | ALDH1A1 (0.51) | ALDH1A1GRM8GRM4MAPTKDM4E | |
| SCHEMBL6671231 | 1.00 | ALDH1A1 (0.51) | ALDH1A1GRM8GRM4MAPTKDM4E | |
| SCHEMBL14255280 | 0.90 | ALDH1A1 (0.55) | ALDH1A1GRM8GRM4MAPTKDM4E | |
| SCHEMBL29557476 | 0.89 | ALDH1A1 (0.51) | ALDH1A1MAPTKDM4EHTTTDP1 | |
| SCHEMBL21981237 | 0.86 | ALDH1A1 (0.49) | ALDH1A1MAPTKDM4EHTTTDP1 | |
| SCHEMBL295431 | 0.84 | ALDH1A1 (0.57) | ALDH1A1GRM8GRM4MAPTKDM4E | |
| SCHEMBL31083493 | 0.84 | ALDH1A1 (0.57) | ALDH1A1GRM8GRM4MAPTKDM4E | |
| SCHEMBL6226433 | 0.84 | ALDH1A1 (0.57) | ALDH1A1GRM8GRM4MAPTKDM4E | |
| Hydrochloric Acid SCHEMBL1567843 | 0.83 | ALDH1A1 (0.56) | ALDH1A1GRM8GRM4MAPTKDM4E | |
| Hydrochloric Acid SCHEMBL29399068 | 0.83 | ALDH1A1 (0.56) | ALDH1A1GRM8GRM4MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3650464-B1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | SHANGPHARMA INNOVATION INC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-20250320181-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | ARTIZAN BIOSCIENCES INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | BAYER AKTIENGESELLSCHAFT (DE) | 2025-08-26 | — | — | US | disclosed |
| US-20250257145-A1 | ADAMTS Binding Immunoglobulins | SANOFI (FR) | 2025-08-14 | — | — | US | disclosed |
| EP-4545553-A2 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | ShangPharma Innovation Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-12209136-B2 | ADAMTS binding immunoglobulins | MERCK PATENT GMBH (DE) | 2025-01-28 | — | — | US | disclosed |
| US-20240425450-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. | 2024-12-26 | — | — | US | disclosed |
| US-12173086-B2 | Alpha-v beta-6 integrin ligands and uses thereof | Arrowhead Pharmaceuticals, Inc. (US) | 2024-12-24 | — | — | US | disclosed |
| EP-3630847-B1 | ADAMTS BINDING IMMUNOGLOBULINS | MERCK PATENT GMBH (DE) | 2024-09-04 | — | — | EP | disclosed |
| EP-4405330-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| EP-4058448-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | Bayer Aktiengesellschaft (DE) | 2022-09-21 | — | — | EP | disclosed |
| EP-4058446-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | Bayer Aktiengesellschaft (DE) | 2022-09-21 | — | — | EP | disclosed |
| US-20220289860-A1 | ADAMTS Binding Immunoglobulins | ABLYNX NV (BE) | 2022-09-15 | — | — | US | disclosed |
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2022-08-30 | — | — | US | disclosed |
| US-20220242908-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-08-04 | — | — | US | disclosed |
| US-20220213142-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-07-07 | — | — | US | disclosed |
| EP-4013860-A1 | CASPASE-2 VARIANTS | Boehringer Ingelheim RCV GmbH & Co KG (AT) | 2022-06-22 | — | — | EP | disclosed |
| EP-3981780-A1 | ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF | Arrowhead Pharmaceuticals, Inc. (US) | 2022-04-13 | — | — | EP | disclosed |
| WO-2022056369-A2 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | Artizan Biosciences, Inc. (US) | 2022-03-17 | — | — | WO | disclosed |
| US-20220024975-A1 | ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF | SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220024975-A1 | ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF | ITGAV, ITGA6, ITGB6 | ALDH1A1 2400/4885GRM8 3216/4885GRM4 3087/4885 |
| US-11427615-B2 | Peptide compound and application thereof, and composition containing peptide compound | KISS1R, VIP, NPY1R | ALDH1A1 4326/4885GRM8 885/4885GRM4 2679/4885 |
| US-20250320181-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | FABP2, APC, STMN1 | ALDH1A1 4878/4885GRM8 3689/4885GRM4 4518/4885 |
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | ADAMTS7, MMP7, ADAM17 | ALDH1A1 3828/4885GRM8 2475/4885GRM4 2866/4885 |
| US-20220213142-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | KISS1R, VIP, SSTR3 | ALDH1A1 4826/4885GRM8 402/4885GRM4 1031/4885 |
| US-20220242908-A1 | PEPTIDE COMPOUND AND APPLICATION THEREOF, AND COMPOSITION CONTAINING PEPTIDE COMPOUND | KISS1R, NPY1R, GLP1R | ALDH1A1 4788/4885GRM8 89/4885GRM4 1415/4885 |
| US-20240425450-A1 | SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS | FABP2, APC, SI | ALDH1A1 4832/4885GRM8 3842/4885GRM4 4478/4885 |
| US-12173086-B2 | Alpha-v beta-6 integrin ligands and uses thereof | ITGAV, ITGA6, ITGB6 | ALDH1A1 2400/4885GRM8 3216/4885GRM4 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.